Cat. No.: X22-05-ZQ128
Adriacin
Synonym: 25316-40-9; Doxorubicin hydrochloride; Doxorubicin HCl; (7S,9S)-7-[(2R,4S,5S,6S)-4-Amino-5-Hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- MDL: MFCD00077757
- CAS Number: 25316-40-9
- Compound CID: 443939
Product Size
20 mg; 25 mg; 50 mg; 100 mg
Properties
Description
Adriacin suppresses cancer cell proliferation by forming a complex with cancer cell DNA and inhibiting DNA and RNA synthetase reactions. It is usually used to improve symptoms of malignant lymphoma, lung cancer, gastrointestinal cancer, breast cancer, bladder tumor, or bone sarcoma. This product can be used in anticancer activity research.
Molecular Formula
C27H29NO11·HCl
Purity
≥98%, determined by HPLC.
Stability
The product is stable for two years when stored at the recommended temperature.
Identity
Confirmed by MS and NMR.
Applications
Adriacin can be used in anticancer activity research.
Storage
Store at 4°C. Protect from light.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products
